Buy Stocks Easy | About Us
May 31, 2020
Buy Stocks Easy | Online Stocks

CORI


Buy Corium International, Inc. Stock (symbol: CORI) Easy Online

Company Name: Corium International, Inc.

Symbol: CORI

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

CORI Current Share Price

Today's CORI ( Corium International, Inc. ) opening price: $

Yesterday's CORI ( Corium International, Inc. ) closing price: $

Corium International, Inc. Stock ( symbol: CORI ) Price Chart since IPO (2014):

12 Months Corium International, Inc. Stock ( symbol: CORI ) Price Chart

Popular Questions about Corium International, Inc. Public Stock ( CORI )

A: Corium International, Inc. stock symbol (also called stock or share ticker) is CORI

A: Corium International, Inc. IPO (Initial Public Offering) took place on 2014

A: Corium International, Inc.'s stock (CORI symbol) price at ther IPO (initial Public Offering) was $

Q: Is CORI stock worth buying at the moment?

A: The CORI stock performance since 2019 are rather disappointing. If you had bought 1 share of Corium International, Inc. stock (symbol: CORI) at the beginning of 2019, at the opening share price of $, you would be left with exactly $ - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Corium International, Inc. Stock Easy Online

Corium International, Inc. Stock Ticker Price Chart since IPO:





Corium International, Inc. Stock Price Yesterday



 


Corium International, Inc. Stock Price – Last Week




 


Corium International, Inc. Stock Price – Last Month




 


Corium International, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/27/1975425/0/en/Corium-Inc-Announces-FDA-Filing-Acceptance-of-New-Drug-Application-for-ADLARITY-donepezil-transdermal-system-for-the-Treatment-of-Alzheimer-s-Disease.html
                            

                                
Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease

                                
                                
MENLO PARK, Calif., Jan.  27, 2020  (GLOBE NEWSWIRE) -- Corium, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/27/1975425/0/en/Corium-Inc-Announces-FDA-Filing-Acceptance-of-New-Drug-Application-for-ADLARITY-donepezil-transdermal-system-for-the-Treatment-of-Alzheimer-s-Disease.html
                            

                                
Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease

                                
                                
MENLO PARK, Calif., Jan.  27, 2020  (GLOBE NEWSWIRE) -- Corium, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/27/1975425/0/en/Corium-Inc-Announces-FDA-Filing-Acceptance-of-New-Drug-Application-for-ADLARITY-donepezil-transdermal-system-for-the-Treatment-of-Alzheimer-s-Disease.html
                            

                                
Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease

                                
                                
MENLO PARK, Calif., Jan.  27, 2020  (GLOBE NEWSWIRE) -- Corium, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/27/1975425/0/en/Corium-Inc-Announces-FDA-Filing-Acceptance-of-New-Drug-Application-for-ADLARITY-donepezil-transdermal-system-for-the-Treatment-of-Alzheimer-s-Disease.html
                            

                                
Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease

                                
                                
MENLO PARK, Calif., Jan.  27, 2020  (GLOBE NEWSWIRE) -- Corium, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/27/1975425/0/en/Corium-Inc-Announces-FDA-Filing-Acceptance-of-New-Drug-Application-for-ADLARITY-donepezil-transdermal-system-for-the-Treatment-of-Alzheimer-s-Disease.html
                            

                                
Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease

                                
                                
MENLO PARK, Calif., Jan.  27, 2020  (GLOBE NEWSWIRE) -- Corium, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/27/1975425/0/en/Corium-Inc-Announces-FDA-Filing-Acceptance-of-New-Drug-Application-for-ADLARITY-donepezil-transdermal-system-for-the-Treatment-of-Alzheimer-s-Disease.html
                            

                                
Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease

                                
                                
MENLO PARK, Calif., Jan.  27, 2020  (GLOBE NEWSWIRE) -- Corium, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/27/1975425/0/en/Corium-Inc-Announces-FDA-Filing-Acceptance-of-New-Drug-Application-for-ADLARITY-donepezil-transdermal-system-for-the-Treatment-of-Alzheimer-s-Disease.html
                            

                                
Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease

                                
                                
MENLO PARK, Calif., Jan.  27, 2020  (GLOBE NEWSWIRE) -- Corium, Inc...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.